New migraine drug on NHS could help thousands of patients in England

Nice approves rimegepant for preventing migraines in cases where at least three previous treatments have failed

Thousands of people in England who get migraines could benefit from a drug that has been approved on the NHS.

The National Institute for Health and Care Excellence (Nice), the drugs regulator, said it was recommending rimegepant for preventing migraines in the approximately 145,000 adults where at least three previous preventive treatments had failed.